nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—TNF—rheumatoid arthritis	0.285	0.678	CbGaD
Pomalidomide—PTGS2—rheumatoid arthritis	0.135	0.322	CbGaD
Pomalidomide—PTGS2—Sulfasalazine—rheumatoid arthritis	0.0472	0.129	CbGbCtD
Pomalidomide—PTGS2—Triamcinolone—rheumatoid arthritis	0.0472	0.129	CbGbCtD
Pomalidomide—PTGS2—Betamethasone—rheumatoid arthritis	0.0405	0.111	CbGbCtD
Pomalidomide—CYP1A2—Leflunomide—rheumatoid arthritis	0.0288	0.0787	CbGbCtD
Pomalidomide—PTGS2—Dexamethasone—rheumatoid arthritis	0.0235	0.0644	CbGbCtD
Pomalidomide—ABCB1—Methylprednisolone—rheumatoid arthritis	0.0205	0.0561	CbGbCtD
Pomalidomide—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0167	0.0456	CbGbCtD
Pomalidomide—ABCB1—Betamethasone—rheumatoid arthritis	0.0133	0.0365	CbGbCtD
Pomalidomide—ABCB1—Prednisolone—rheumatoid arthritis	0.0132	0.036	CbGbCtD
Pomalidomide—ABCB1—Hydrocortisone—rheumatoid arthritis	0.0125	0.0341	CbGbCtD
Pomalidomide—ABCB1—Prednisone—rheumatoid arthritis	0.0124	0.034	CbGbCtD
Pomalidomide—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.0123	0.0336	CbGbCtD
Pomalidomide—ABCB1—Cyclosporine—rheumatoid arthritis	0.0118	0.0322	CbGbCtD
Pomalidomide—CYP3A4—Triamcinolone—rheumatoid arthritis	0.00932	0.0255	CbGbCtD
Pomalidomide—CYP3A4—Betamethasone—rheumatoid arthritis	0.008	0.0219	CbGbCtD
Pomalidomide—CYP3A4—Prednisolone—rheumatoid arthritis	0.00789	0.0216	CbGbCtD
Pomalidomide—ABCB1—Dexamethasone—rheumatoid arthritis	0.00776	0.0212	CbGbCtD
Pomalidomide—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.00748	0.0205	CbGbCtD
Pomalidomide—CYP3A4—Prednisone—rheumatoid arthritis	0.00745	0.0204	CbGbCtD
Pomalidomide—CYP3A4—Cyclosporine—rheumatoid arthritis	0.00706	0.0193	CbGbCtD
Pomalidomide—ABCB1—Methotrexate—rheumatoid arthritis	0.00624	0.0171	CbGbCtD
Pomalidomide—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00465	0.0127	CbGbCtD
Pomalidomide—Lenalidomide—TNFSF11—rheumatoid arthritis	0.0038	0.596	CrCbGaD
Pomalidomide—Thalidomide—NFKB1—rheumatoid arthritis	0.00152	0.238	CrCbGaD
Pomalidomide—PTGS2—skeletal joint—rheumatoid arthritis	0.000738	0.166	CbGeAlD
Pomalidomide—PTGS2—synovial membrane of synovial joint—rheumatoid arthritis	0.00056	0.126	CbGeAlD
Pomalidomide—CRBN—parotid gland—rheumatoid arthritis	0.000515	0.116	CbGeAlD
Pomalidomide—PTGS2—cartilage tissue—rheumatoid arthritis	0.000496	0.111	CbGeAlD
Pomalidomide—CRBN—saliva-secreting gland—rheumatoid arthritis	0.000493	0.111	CbGeAlD
Pomalidomide—Thalidomide—TNF—rheumatoid arthritis	0.000466	0.073	CrCbGaD
Pomalidomide—PTGS2—Fluocinonide—Methylprednisolone—rheumatoid arthritis	0.000436	0.159	CbGdCrCtD
Pomalidomide—PTGS2—Fluocinonide—Betamethasone—rheumatoid arthritis	0.000429	0.156	CbGdCrCtD
Pomalidomide—PTGS2—Fluocinonide—Dexamethasone—rheumatoid arthritis	0.000429	0.156	CbGdCrCtD
Pomalidomide—PTGS2—Fluocinonide—Triamcinolone—rheumatoid arthritis	0.000419	0.153	CbGdCrCtD
Pomalidomide—Lenalidomide—PTGS2—rheumatoid arthritis	0.000369	0.0579	CrCbGaD
Pomalidomide—CRBN—lymphoid tissue—rheumatoid arthritis	0.000331	0.0743	CbGeAlD
Pomalidomide—CRBN—digestive system—rheumatoid arthritis	0.000327	0.0734	CbGeAlD
Pomalidomide—CRBN—tendon—rheumatoid arthritis	0.000311	0.0699	CbGeAlD
Pomalidomide—PTGS2—Fluticasone Propionate—Methylprednisolone—rheumatoid arthritis	0.000263	0.0958	CbGdCrCtD
Pomalidomide—PTGS2—Fluticasone Propionate—Betamethasone—rheumatoid arthritis	0.000259	0.0942	CbGdCrCtD
Pomalidomide—PTGS2—Fluticasone Propionate—Dexamethasone—rheumatoid arthritis	0.000259	0.0942	CbGdCrCtD
Pomalidomide—PTGS2—Fluticasone Propionate—Triamcinolone—rheumatoid arthritis	0.000253	0.0921	CbGdCrCtD
Pomalidomide—Thalidomide—PTGS2—rheumatoid arthritis	0.000221	0.0347	CrCbGaD
Pomalidomide—Confusional state—Cyclosporine—rheumatoid arthritis	0.000133	0.00129	CcSEcCtD
Pomalidomide—Vertigo—Prednisolone—rheumatoid arthritis	0.000132	0.00128	CcSEcCtD
Pomalidomide—Infection—Cyclosporine—rheumatoid arthritis	0.000131	0.00127	CcSEcCtD
Pomalidomide—Back pain—Triamcinolone—rheumatoid arthritis	0.000131	0.00127	CcSEcCtD
Pomalidomide—Nervous system disorder—Cyclosporine—rheumatoid arthritis	0.000129	0.00125	CcSEcCtD
Pomalidomide—Thrombocytopenia—Cyclosporine—rheumatoid arthritis	0.000129	0.00125	CcSEcCtD
Pomalidomide—Vertigo—Hydrocortisone—rheumatoid arthritis	0.000129	0.00125	CcSEcCtD
Pomalidomide—Skin disorder—Cyclosporine—rheumatoid arthritis	0.000128	0.00124	CcSEcCtD
Pomalidomide—Angiopathy—Dexamethasone—rheumatoid arthritis	0.000128	0.00124	CcSEcCtD
Pomalidomide—Angiopathy—Betamethasone—rheumatoid arthritis	0.000128	0.00124	CcSEcCtD
Pomalidomide—Hyperhidrosis—Cyclosporine—rheumatoid arthritis	0.000128	0.00123	CcSEcCtD
Pomalidomide—Hypersensitivity—Leflunomide—rheumatoid arthritis	0.000126	0.00122	CcSEcCtD
Pomalidomide—Diarrhoea—Azathioprine—rheumatoid arthritis	0.000124	0.0012	CcSEcCtD
Pomalidomide—PTGS2—connective tissue—rheumatoid arthritis	0.000123	0.0277	CbGeAlD
Pomalidomide—Asthenia—Leflunomide—rheumatoid arthritis	0.000123	0.00119	CcSEcCtD
Pomalidomide—Anxiety—Hydrocortisone—rheumatoid arthritis	0.000122	0.00118	CcSEcCtD
Pomalidomide—Pancytopenia—Methotrexate—rheumatoid arthritis	0.000122	0.00118	CcSEcCtD
Pomalidomide—Vertigo—Triamcinolone—rheumatoid arthritis	0.000122	0.00118	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—rheumatoid arthritis	0.000121	0.00118	CcSEcCtD
Pomalidomide—Vertigo—Methylprednisolone—rheumatoid arthritis	0.000121	0.00117	CcSEcCtD
Pomalidomide—Pruritus—Leflunomide—rheumatoid arthritis	0.000121	0.00117	CcSEcCtD
Pomalidomide—Connective tissue disorder—Prednisone—rheumatoid arthritis	0.000121	0.00117	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Cyclosporine—rheumatoid arthritis	0.00012	0.00116	CcSEcCtD
Pomalidomide—Neutropenia—Methotrexate—rheumatoid arthritis	0.00012	0.00116	CcSEcCtD
Pomalidomide—Dizziness—Azathioprine—rheumatoid arthritis	0.00012	0.00116	CcSEcCtD
Pomalidomide—Insomnia—Cyclosporine—rheumatoid arthritis	0.000119	0.00115	CcSEcCtD
Pomalidomide—Upper respiratory tract infection—Methotrexate—rheumatoid arthritis	0.000119	0.00115	CcSEcCtD
Pomalidomide—Cough—Triamcinolone—rheumatoid arthritis	0.000118	0.00114	CcSEcCtD
Pomalidomide—Dyspnoea—Cyclosporine—rheumatoid arthritis	0.000118	0.00114	CcSEcCtD
Pomalidomide—Diarrhoea—Leflunomide—rheumatoid arthritis	0.000117	0.00113	CcSEcCtD
Pomalidomide—Infection—Hydrocortisone—rheumatoid arthritis	0.000116	0.00113	CcSEcCtD
Pomalidomide—Hyperhidrosis—Prednisolone—rheumatoid arthritis	0.000116	0.00112	CcSEcCtD
Pomalidomide—Vomiting—Azathioprine—rheumatoid arthritis	0.000115	0.00111	CcSEcCtD
Pomalidomide—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	0.000115	0.00111	CcSEcCtD
Pomalidomide—Pneumonia—Methotrexate—rheumatoid arthritis	0.000115	0.00111	CcSEcCtD
Pomalidomide—Arthralgia—Methylprednisolone—rheumatoid arthritis	0.000115	0.00111	CcSEcCtD
Pomalidomide—Decreased appetite—Cyclosporine—rheumatoid arthritis	0.000115	0.00111	CcSEcCtD
Pomalidomide—Anxiety—Methylprednisolone—rheumatoid arthritis	0.000115	0.00111	CcSEcCtD
Pomalidomide—Infestation—Methotrexate—rheumatoid arthritis	0.000114	0.00111	CcSEcCtD
Pomalidomide—Infestation NOS—Methotrexate—rheumatoid arthritis	0.000114	0.00111	CcSEcCtD
Pomalidomide—Rash—Azathioprine—rheumatoid arthritis	0.000114	0.0011	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	0.000114	0.0011	CcSEcCtD
Pomalidomide—Dermatitis—Azathioprine—rheumatoid arthritis	0.000114	0.0011	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	0.000114	0.0011	CcSEcCtD
Pomalidomide—Skin disorder—Hydrocortisone—rheumatoid arthritis	0.000114	0.0011	CcSEcCtD
Pomalidomide—Fatigue—Cyclosporine—rheumatoid arthritis	0.000114	0.0011	CcSEcCtD
Pomalidomide—Headache—Azathioprine—rheumatoid arthritis	0.000113	0.0011	CcSEcCtD
Pomalidomide—Hyperhidrosis—Hydrocortisone—rheumatoid arthritis	0.000113	0.0011	CcSEcCtD
Pomalidomide—Dizziness—Leflunomide—rheumatoid arthritis	0.000113	0.00109	CcSEcCtD
Pomalidomide—Constipation—Cyclosporine—rheumatoid arthritis	0.000113	0.00109	CcSEcCtD
Pomalidomide—Pain—Cyclosporine—rheumatoid arthritis	0.000113	0.00109	CcSEcCtD
Pomalidomide—Renal failure—Methotrexate—rheumatoid arthritis	0.000112	0.00109	CcSEcCtD
Pomalidomide—Angiopathy—Prednisone—rheumatoid arthritis	0.000111	0.00108	CcSEcCtD
Pomalidomide—Confusional state—Methylprednisolone—rheumatoid arthritis	0.000111	0.00107	CcSEcCtD
Pomalidomide—Vertigo—Dexamethasone—rheumatoid arthritis	0.00011	0.00107	CcSEcCtD
Pomalidomide—Vertigo—Betamethasone—rheumatoid arthritis	0.00011	0.00107	CcSEcCtD
Pomalidomide—Infection—Triamcinolone—rheumatoid arthritis	0.00011	0.00106	CcSEcCtD
Pomalidomide—Infection—Methylprednisolone—rheumatoid arthritis	0.000109	0.00106	CcSEcCtD
Pomalidomide—Feeling abnormal—Cyclosporine—rheumatoid arthritis	0.000109	0.00105	CcSEcCtD
Pomalidomide—Vomiting—Leflunomide—rheumatoid arthritis	0.000109	0.00105	CcSEcCtD
Pomalidomide—Insomnia—Prednisolone—rheumatoid arthritis	0.000109	0.00105	CcSEcCtD
Pomalidomide—Hepatobiliary disease—Methotrexate—rheumatoid arthritis	0.000108	0.00105	CcSEcCtD
Pomalidomide—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.000108	0.00105	CcSEcCtD
Pomalidomide—Epistaxis—Methotrexate—rheumatoid arthritis	0.000108	0.00104	CcSEcCtD
Pomalidomide—Rash—Leflunomide—rheumatoid arthritis	0.000108	0.00104	CcSEcCtD
Pomalidomide—Dermatitis—Leflunomide—rheumatoid arthritis	0.000108	0.00104	CcSEcCtD
Pomalidomide—Mental disorder—Prednisone—rheumatoid arthritis	0.000108	0.00104	CcSEcCtD
Pomalidomide—CYP1A2—digestive system—rheumatoid arthritis	0.000108	0.0241	CbGeAlD
Pomalidomide—Nausea—Azathioprine—rheumatoid arthritis	0.000108	0.00104	CcSEcCtD
Pomalidomide—Headache—Leflunomide—rheumatoid arthritis	0.000107	0.00104	CcSEcCtD
Pomalidomide—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.000107	0.00104	CcSEcCtD
Pomalidomide—Malnutrition—Prednisone—rheumatoid arthritis	0.000107	0.00103	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	0.000107	0.00103	CcSEcCtD
Pomalidomide—Hyperhidrosis—Triamcinolone—rheumatoid arthritis	0.000107	0.00103	CcSEcCtD
Pomalidomide—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	0.000106	0.00103	CcSEcCtD
Pomalidomide—Insomnia—Hydrocortisone—rheumatoid arthritis	0.000106	0.00103	CcSEcCtD
Pomalidomide—Body temperature increased—Cyclosporine—rheumatoid arthritis	0.000104	0.00101	CcSEcCtD
Pomalidomide—Anxiety—Betamethasone—rheumatoid arthritis	0.000104	0.00101	CcSEcCtD
Pomalidomide—Anxiety—Dexamethasone—rheumatoid arthritis	0.000104	0.00101	CcSEcCtD
Pomalidomide—Pain—Prednisolone—rheumatoid arthritis	0.000103	0.000993	CcSEcCtD
Pomalidomide—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000102	0.000986	CcSEcCtD
Pomalidomide—Nausea—Leflunomide—rheumatoid arthritis	0.000102	0.000982	CcSEcCtD
Pomalidomide—Urinary tract disorder—Methotrexate—rheumatoid arthritis	0.000101	0.000981	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000101	0.000979	CcSEcCtD
Pomalidomide—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000101	0.000978	CcSEcCtD
Pomalidomide—Urethral disorder—Methotrexate—rheumatoid arthritis	0.000101	0.000973	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000101	0.000973	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.0001	0.000971	CcSEcCtD
Pomalidomide—Pain—Hydrocortisone—rheumatoid arthritis	0.0001	0.00097	CcSEcCtD
Pomalidomide—Insomnia—Triamcinolone—rheumatoid arthritis	9.98e-05	0.000966	CcSEcCtD
Pomalidomide—Insomnia—Methylprednisolone—rheumatoid arthritis	9.96e-05	0.000964	CcSEcCtD
Pomalidomide—Infection—Dexamethasone—rheumatoid arthritis	9.95e-05	0.000963	CcSEcCtD
Pomalidomide—Infection—Betamethasone—rheumatoid arthritis	9.95e-05	0.000963	CcSEcCtD
Pomalidomide—Feeling abnormal—Prednisolone—rheumatoid arthritis	9.89e-05	0.000957	CcSEcCtD
Pomalidomide—Anaemia—Prednisone—rheumatoid arthritis	9.88e-05	0.000956	CcSEcCtD
Pomalidomide—Dyspnoea—Triamcinolone—rheumatoid arthritis	9.84e-05	0.000952	CcSEcCtD
Pomalidomide—Nervous system disorder—Dexamethasone—rheumatoid arthritis	9.82e-05	0.000951	CcSEcCtD
Pomalidomide—Nervous system disorder—Betamethasone—rheumatoid arthritis	9.82e-05	0.000951	CcSEcCtD
Pomalidomide—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	9.81e-05	0.000949	CcSEcCtD
Pomalidomide—Thrombocytopenia—Betamethasone—rheumatoid arthritis	9.81e-05	0.000949	CcSEcCtD
Pomalidomide—Hypersensitivity—Cyclosporine—rheumatoid arthritis	9.72e-05	0.000941	CcSEcCtD
Pomalidomide—Hyperhidrosis—Betamethasone—rheumatoid arthritis	9.68e-05	0.000937	CcSEcCtD
Pomalidomide—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	9.68e-05	0.000937	CcSEcCtD
Pomalidomide—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	9.66e-05	0.000935	CcSEcCtD
Pomalidomide—Vertigo—Prednisone—rheumatoid arthritis	9.6e-05	0.000929	CcSEcCtD
Pomalidomide—Cardiac disorder—Methotrexate—rheumatoid arthritis	9.52e-05	0.000922	CcSEcCtD
Pomalidomide—Fatigue—Triamcinolone—rheumatoid arthritis	9.52e-05	0.000921	CcSEcCtD
Pomalidomide—Fatigue—Methylprednisolone—rheumatoid arthritis	9.5e-05	0.000919	CcSEcCtD
Pomalidomide—Asthenia—Cyclosporine—rheumatoid arthritis	9.46e-05	0.000916	CcSEcCtD
Pomalidomide—Pain—Triamcinolone—rheumatoid arthritis	9.44e-05	0.000913	CcSEcCtD
Pomalidomide—Pruritus—Cyclosporine—rheumatoid arthritis	9.33e-05	0.000903	CcSEcCtD
Pomalidomide—Angiopathy—Methotrexate—rheumatoid arthritis	9.31e-05	0.000901	CcSEcCtD
Pomalidomide—Body temperature increased—Hydrocortisone—rheumatoid arthritis	9.27e-05	0.000897	CcSEcCtD
Pomalidomide—Mediastinal disorder—Methotrexate—rheumatoid arthritis	9.25e-05	0.000895	CcSEcCtD
Pomalidomide—Chills—Methotrexate—rheumatoid arthritis	9.21e-05	0.000891	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	9.13e-05	0.000883	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	9.13e-05	0.000883	CcSEcCtD
Pomalidomide—Arthralgia—Prednisone—rheumatoid arthritis	9.1e-05	0.000881	CcSEcCtD
Pomalidomide—Feeling abnormal—Triamcinolone—rheumatoid arthritis	9.1e-05	0.00088	CcSEcCtD
Pomalidomide—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	9.08e-05	0.000878	CcSEcCtD
Pomalidomide—Anxiety—Prednisone—rheumatoid arthritis	9.07e-05	0.000877	CcSEcCtD
Pomalidomide—Insomnia—Betamethasone—rheumatoid arthritis	9.06e-05	0.000877	CcSEcCtD
Pomalidomide—Insomnia—Dexamethasone—rheumatoid arthritis	9.06e-05	0.000877	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	9.04e-05	0.000874	CcSEcCtD
Pomalidomide—Diarrhoea—Cyclosporine—rheumatoid arthritis	9.03e-05	0.000873	CcSEcCtD
Pomalidomide—PTGS2—lymphoid tissue—rheumatoid arthritis	9.02e-05	0.0202	CbGeAlD
Pomalidomide—Mental disorder—Methotrexate—rheumatoid arthritis	8.99e-05	0.00087	CcSEcCtD
Pomalidomide—Malnutrition—Methotrexate—rheumatoid arthritis	8.93e-05	0.000864	CcSEcCtD
Pomalidomide—PTGS2—digestive system—rheumatoid arthritis	8.91e-05	0.02	CbGeAlD
Pomalidomide—Hypersensitivity—Prednisolone—rheumatoid arthritis	8.84e-05	0.000856	CcSEcCtD
Pomalidomide—Body temperature increased—Triamcinolone—rheumatoid arthritis	8.73e-05	0.000844	CcSEcCtD
Pomalidomide—Dizziness—Cyclosporine—rheumatoid arthritis	8.72e-05	0.000844	CcSEcCtD
Pomalidomide—Decreased appetite—Betamethasone—rheumatoid arthritis	8.71e-05	0.000843	CcSEcCtD
Pomalidomide—Decreased appetite—Dexamethasone—rheumatoid arthritis	8.71e-05	0.000843	CcSEcCtD
Pomalidomide—Infection—Prednisone—rheumatoid arthritis	8.67e-05	0.000839	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	8.65e-05	0.000837	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	8.65e-05	0.000837	CcSEcCtD
Pomalidomide—Back pain—Methotrexate—rheumatoid arthritis	8.64e-05	0.000836	CcSEcCtD
Pomalidomide—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	8.64e-05	0.000836	CcSEcCtD
Pomalidomide—Fatigue—Dexamethasone—rheumatoid arthritis	8.64e-05	0.000836	CcSEcCtD
Pomalidomide—Fatigue—Betamethasone—rheumatoid arthritis	8.64e-05	0.000836	CcSEcCtD
Pomalidomide—Pain—Dexamethasone—rheumatoid arthritis	8.57e-05	0.000829	CcSEcCtD
Pomalidomide—Pain—Betamethasone—rheumatoid arthritis	8.57e-05	0.000829	CcSEcCtD
Pomalidomide—Nervous system disorder—Prednisone—rheumatoid arthritis	8.55e-05	0.000828	CcSEcCtD
Pomalidomide—PTGS2—tendon—rheumatoid arthritis	8.48e-05	0.019	CbGeAlD
Pomalidomide—Skin disorder—Prednisone—rheumatoid arthritis	8.47e-05	0.00082	CcSEcCtD
Pomalidomide—Hyperhidrosis—Prednisone—rheumatoid arthritis	8.43e-05	0.000816	CcSEcCtD
Pomalidomide—Asthenia—Hydrocortisone—rheumatoid arthritis	8.41e-05	0.000814	CcSEcCtD
Pomalidomide—Vomiting—Cyclosporine—rheumatoid arthritis	8.39e-05	0.000812	CcSEcCtD
Pomalidomide—Rash—Cyclosporine—rheumatoid arthritis	8.32e-05	0.000805	CcSEcCtD
Pomalidomide—Dermatitis—Cyclosporine—rheumatoid arthritis	8.31e-05	0.000804	CcSEcCtD
Pomalidomide—Pruritus—Hydrocortisone—rheumatoid arthritis	8.29e-05	0.000803	CcSEcCtD
Pomalidomide—Headache—Cyclosporine—rheumatoid arthritis	8.26e-05	0.0008	CcSEcCtD
Pomalidomide—Anaemia—Methotrexate—rheumatoid arthritis	8.26e-05	0.000799	CcSEcCtD
Pomalidomide—Feeling abnormal—Dexamethasone—rheumatoid arthritis	8.25e-05	0.000799	CcSEcCtD
Pomalidomide—Feeling abnormal—Betamethasone—rheumatoid arthritis	8.25e-05	0.000799	CcSEcCtD
Pomalidomide—Hypersensitivity—Triamcinolone—rheumatoid arthritis	8.13e-05	0.000787	CcSEcCtD
Pomalidomide—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	8.12e-05	0.000785	CcSEcCtD
Pomalidomide—Vertigo—Methotrexate—rheumatoid arthritis	8.03e-05	0.000777	CcSEcCtD
Pomalidomide—Diarrhoea—Hydrocortisone—rheumatoid arthritis	8.02e-05	0.000776	CcSEcCtD
Pomalidomide—Leukopenia—Methotrexate—rheumatoid arthritis	8e-05	0.000774	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	7.95e-05	0.000769	CcSEcCtD
Pomalidomide—Dizziness—Prednisolone—rheumatoid arthritis	7.94e-05	0.000768	CcSEcCtD
Pomalidomide—Asthenia—Triamcinolone—rheumatoid arthritis	7.92e-05	0.000766	CcSEcCtD
Pomalidomide—Body temperature increased—Betamethasone—rheumatoid arthritis	7.92e-05	0.000766	CcSEcCtD
Pomalidomide—Body temperature increased—Dexamethasone—rheumatoid arthritis	7.92e-05	0.000766	CcSEcCtD
Pomalidomide—Asthenia—Methylprednisolone—rheumatoid arthritis	7.9e-05	0.000765	CcSEcCtD
Pomalidomide—Insomnia—Prednisone—rheumatoid arthritis	7.89e-05	0.000763	CcSEcCtD
Pomalidomide—Nausea—Cyclosporine—rheumatoid arthritis	7.84e-05	0.000758	CcSEcCtD
Pomalidomide—Pruritus—Triamcinolone—rheumatoid arthritis	7.81e-05	0.000756	CcSEcCtD
Pomalidomide—Cough—Methotrexate—rheumatoid arthritis	7.79e-05	0.000754	CcSEcCtD
Pomalidomide—Pruritus—Methylprednisolone—rheumatoid arthritis	7.79e-05	0.000754	CcSEcCtD
Pomalidomide—CYP3A4—digestive system—rheumatoid arthritis	7.79e-05	0.0175	CbGeAlD
Pomalidomide—Dizziness—Hydrocortisone—rheumatoid arthritis	7.75e-05	0.00075	CcSEcCtD
Pomalidomide—Arthralgia—Methotrexate—rheumatoid arthritis	7.6e-05	0.000736	CcSEcCtD
Pomalidomide—Decreased appetite—Prednisone—rheumatoid arthritis	7.58e-05	0.000734	CcSEcCtD
Pomalidomide—Rash—Prednisolone—rheumatoid arthritis	7.57e-05	0.000732	CcSEcCtD
Pomalidomide—Dermatitis—Prednisolone—rheumatoid arthritis	7.56e-05	0.000732	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	7.55e-05	0.000731	CcSEcCtD
Pomalidomide—Diarrhoea—Methylprednisolone—rheumatoid arthritis	7.54e-05	0.000729	CcSEcCtD
Pomalidomide—Fatigue—Prednisone—rheumatoid arthritis	7.52e-05	0.000728	CcSEcCtD
Pomalidomide—Headache—Prednisolone—rheumatoid arthritis	7.52e-05	0.000728	CcSEcCtD
Pomalidomide—Constipation—Prednisone—rheumatoid arthritis	7.46e-05	0.000722	CcSEcCtD
Pomalidomide—Vomiting—Hydrocortisone—rheumatoid arthritis	7.45e-05	0.000721	CcSEcCtD
Pomalidomide—Rash—Hydrocortisone—rheumatoid arthritis	7.39e-05	0.000715	CcSEcCtD
Pomalidomide—Dermatitis—Hydrocortisone—rheumatoid arthritis	7.39e-05	0.000715	CcSEcCtD
Pomalidomide—Confusional state—Methotrexate—rheumatoid arthritis	7.35e-05	0.000711	CcSEcCtD
Pomalidomide—Headache—Hydrocortisone—rheumatoid arthritis	7.34e-05	0.000711	CcSEcCtD
Pomalidomide—Dizziness—Triamcinolone—rheumatoid arthritis	7.3e-05	0.000706	CcSEcCtD
Pomalidomide—Dizziness—Methylprednisolone—rheumatoid arthritis	7.28e-05	0.000705	CcSEcCtD
Pomalidomide—Infection—Methotrexate—rheumatoid arthritis	7.24e-05	0.000701	CcSEcCtD
Pomalidomide—Feeling abnormal—Prednisone—rheumatoid arthritis	7.19e-05	0.000696	CcSEcCtD
Pomalidomide—Asthenia—Betamethasone—rheumatoid arthritis	7.19e-05	0.000695	CcSEcCtD
Pomalidomide—Asthenia—Dexamethasone—rheumatoid arthritis	7.19e-05	0.000695	CcSEcCtD
Pomalidomide—Nervous system disorder—Methotrexate—rheumatoid arthritis	7.15e-05	0.000692	CcSEcCtD
Pomalidomide—Thrombocytopenia—Methotrexate—rheumatoid arthritis	7.14e-05	0.000691	CcSEcCtD
Pomalidomide—Nausea—Prednisolone—rheumatoid arthritis	7.13e-05	0.00069	CcSEcCtD
Pomalidomide—Pruritus—Betamethasone—rheumatoid arthritis	7.09e-05	0.000686	CcSEcCtD
Pomalidomide—Pruritus—Dexamethasone—rheumatoid arthritis	7.09e-05	0.000686	CcSEcCtD
Pomalidomide—Skin disorder—Methotrexate—rheumatoid arthritis	7.08e-05	0.000685	CcSEcCtD
Pomalidomide—Hyperhidrosis—Methotrexate—rheumatoid arthritis	7.05e-05	0.000682	CcSEcCtD
Pomalidomide—Vomiting—Triamcinolone—rheumatoid arthritis	7.02e-05	0.000679	CcSEcCtD
Pomalidomide—Vomiting—Methylprednisolone—rheumatoid arthritis	7e-05	0.000678	CcSEcCtD
Pomalidomide—Nausea—Hydrocortisone—rheumatoid arthritis	6.96e-05	0.000674	CcSEcCtD
Pomalidomide—Rash—Triamcinolone—rheumatoid arthritis	6.96e-05	0.000674	CcSEcCtD
Pomalidomide—Dermatitis—Triamcinolone—rheumatoid arthritis	6.95e-05	0.000673	CcSEcCtD
Pomalidomide—Rash—Methylprednisolone—rheumatoid arthritis	6.94e-05	0.000672	CcSEcCtD
Pomalidomide—Dermatitis—Methylprednisolone—rheumatoid arthritis	6.94e-05	0.000671	CcSEcCtD
Pomalidomide—Headache—Triamcinolone—rheumatoid arthritis	6.92e-05	0.000669	CcSEcCtD
Pomalidomide—Headache—Methylprednisolone—rheumatoid arthritis	6.9e-05	0.000668	CcSEcCtD
Pomalidomide—Body temperature increased—Prednisone—rheumatoid arthritis	6.9e-05	0.000667	CcSEcCtD
Pomalidomide—Diarrhoea—Dexamethasone—rheumatoid arthritis	6.85e-05	0.000663	CcSEcCtD
Pomalidomide—Diarrhoea—Betamethasone—rheumatoid arthritis	6.85e-05	0.000663	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	6.64e-05	0.000643	CcSEcCtD
Pomalidomide—Dizziness—Dexamethasone—rheumatoid arthritis	6.62e-05	0.000641	CcSEcCtD
Pomalidomide—Dizziness—Betamethasone—rheumatoid arthritis	6.62e-05	0.000641	CcSEcCtD
Pomalidomide—Insomnia—Methotrexate—rheumatoid arthritis	6.59e-05	0.000638	CcSEcCtD
Pomalidomide—Nausea—Triamcinolone—rheumatoid arthritis	6.56e-05	0.000635	CcSEcCtD
Pomalidomide—Nausea—Methylprednisolone—rheumatoid arthritis	6.54e-05	0.000633	CcSEcCtD
Pomalidomide—Dyspnoea—Methotrexate—rheumatoid arthritis	6.5e-05	0.000629	CcSEcCtD
Pomalidomide—Hypersensitivity—Prednisone—rheumatoid arthritis	6.43e-05	0.000622	CcSEcCtD
Pomalidomide—Vomiting—Dexamethasone—rheumatoid arthritis	6.37e-05	0.000616	CcSEcCtD
Pomalidomide—Vomiting—Betamethasone—rheumatoid arthritis	6.37e-05	0.000616	CcSEcCtD
Pomalidomide—Decreased appetite—Methotrexate—rheumatoid arthritis	6.34e-05	0.000613	CcSEcCtD
Pomalidomide—Rash—Betamethasone—rheumatoid arthritis	6.32e-05	0.000611	CcSEcCtD
Pomalidomide—Rash—Dexamethasone—rheumatoid arthritis	6.32e-05	0.000611	CcSEcCtD
Pomalidomide—Dermatitis—Betamethasone—rheumatoid arthritis	6.31e-05	0.000611	CcSEcCtD
Pomalidomide—Dermatitis—Dexamethasone—rheumatoid arthritis	6.31e-05	0.000611	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	6.29e-05	0.000609	CcSEcCtD
Pomalidomide—Fatigue—Methotrexate—rheumatoid arthritis	6.29e-05	0.000608	CcSEcCtD
Pomalidomide—Headache—Betamethasone—rheumatoid arthritis	6.28e-05	0.000607	CcSEcCtD
Pomalidomide—Headache—Dexamethasone—rheumatoid arthritis	6.28e-05	0.000607	CcSEcCtD
Pomalidomide—Asthenia—Prednisone—rheumatoid arthritis	6.26e-05	0.000606	CcSEcCtD
Pomalidomide—Pain—Methotrexate—rheumatoid arthritis	6.23e-05	0.000603	CcSEcCtD
Pomalidomide—Pruritus—Prednisone—rheumatoid arthritis	6.17e-05	0.000597	CcSEcCtD
Pomalidomide—Feeling abnormal—Methotrexate—rheumatoid arthritis	6.01e-05	0.000581	CcSEcCtD
Pomalidomide—Diarrhoea—Prednisone—rheumatoid arthritis	5.97e-05	0.000578	CcSEcCtD
Pomalidomide—Nausea—Betamethasone—rheumatoid arthritis	5.95e-05	0.000576	CcSEcCtD
Pomalidomide—Nausea—Dexamethasone—rheumatoid arthritis	5.95e-05	0.000576	CcSEcCtD
Pomalidomide—Dizziness—Prednisone—rheumatoid arthritis	5.77e-05	0.000558	CcSEcCtD
Pomalidomide—Body temperature increased—Methotrexate—rheumatoid arthritis	5.76e-05	0.000558	CcSEcCtD
Pomalidomide—ABCB1—lymphoid tissue—rheumatoid arthritis	5.58e-05	0.0125	CbGeAlD
Pomalidomide—Vomiting—Prednisone—rheumatoid arthritis	5.55e-05	0.000537	CcSEcCtD
Pomalidomide—ABCB1—digestive system—rheumatoid arthritis	5.51e-05	0.0124	CbGeAlD
Pomalidomide—Rash—Prednisone—rheumatoid arthritis	5.5e-05	0.000532	CcSEcCtD
Pomalidomide—Dermatitis—Prednisone—rheumatoid arthritis	5.49e-05	0.000532	CcSEcCtD
Pomalidomide—Headache—Prednisone—rheumatoid arthritis	5.46e-05	0.000529	CcSEcCtD
Pomalidomide—Hypersensitivity—Methotrexate—rheumatoid arthritis	5.37e-05	0.00052	CcSEcCtD
Pomalidomide—Asthenia—Methotrexate—rheumatoid arthritis	5.23e-05	0.000506	CcSEcCtD
Pomalidomide—Nausea—Prednisone—rheumatoid arthritis	5.18e-05	0.000501	CcSEcCtD
Pomalidomide—Pruritus—Methotrexate—rheumatoid arthritis	5.16e-05	0.000499	CcSEcCtD
Pomalidomide—Diarrhoea—Methotrexate—rheumatoid arthritis	4.99e-05	0.000483	CcSEcCtD
Pomalidomide—Dizziness—Methotrexate—rheumatoid arthritis	4.82e-05	0.000466	CcSEcCtD
Pomalidomide—CYP1A2—Melatonin metabolism and effects—NFKB1—rheumatoid arthritis	4.73e-05	0.000487	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—IL1B—rheumatoid arthritis	4.71e-05	0.000485	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—IL2—rheumatoid arthritis	4.69e-05	0.000484	CbGpPWpGaD
Pomalidomide—Vomiting—Methotrexate—rheumatoid arthritis	4.64e-05	0.000449	CcSEcCtD
Pomalidomide—Rash—Methotrexate—rheumatoid arthritis	4.6e-05	0.000445	CcSEcCtD
Pomalidomide—Dermatitis—Methotrexate—rheumatoid arthritis	4.59e-05	0.000444	CcSEcCtD
Pomalidomide—PTGS2—Spinal Cord Injury—LEP—rheumatoid arthritis	4.57e-05	0.000471	CbGpPWpGaD
Pomalidomide—Headache—Methotrexate—rheumatoid arthritis	4.57e-05	0.000442	CcSEcCtD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	4.53e-05	0.000467	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	4.53e-05	0.000467	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—ALB—rheumatoid arthritis	4.53e-05	0.000466	CbGpPWpGaD
Pomalidomide—PTGS2—Aryl Hydrocarbon Receptor—TNF—rheumatoid arthritis	4.49e-05	0.000463	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TLR4—rheumatoid arthritis	4.48e-05	0.000461	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—STAT1—rheumatoid arthritis	4.47e-05	0.000461	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—MMP9—rheumatoid arthritis	4.44e-05	0.000458	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—LCN2—rheumatoid arthritis	4.41e-05	0.000454	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—IL6—rheumatoid arthritis	4.39e-05	0.000452	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—HLA-DRB1—rheumatoid arthritis	4.37e-05	0.00045	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—FADS2—rheumatoid arthritis	4.35e-05	0.000449	CbGpPWpGaD
Pomalidomide—Nausea—Methotrexate—rheumatoid arthritis	4.33e-05	0.000419	CcSEcCtD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—rheumatoid arthritis	4.31e-05	0.000444	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—ICAM1—rheumatoid arthritis	4.29e-05	0.000442	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—NOS2—rheumatoid arthritis	4.26e-05	0.000439	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	4.22e-05	0.000434	CbGpPWpGaD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—rheumatoid arthritis	4.2e-05	0.000433	CbGpPWpGaD
Pomalidomide—TNF—Alzheimers Disease—TP53—rheumatoid arthritis	4.15e-05	0.000428	CbGpPWpGaD
Pomalidomide—PTGS2—C-MYB transcription factor network—CD4—rheumatoid arthritis	4.14e-05	0.000427	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL1B—rheumatoid arthritis	4.13e-05	0.000426	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—IFNG—rheumatoid arthritis	4.13e-05	0.000426	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—CD80—rheumatoid arthritis	4.04e-05	0.000416	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—PTPRC—rheumatoid arthritis	4.01e-05	0.000413	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—TP53—rheumatoid arthritis	3.96e-05	0.000408	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—CXCL8—rheumatoid arthritis	3.93e-05	0.000405	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—rheumatoid arthritis	3.93e-05	0.000405	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—NFKB1—rheumatoid arthritis	3.86e-05	0.000397	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—CCL2—rheumatoid arthritis	3.84e-05	0.000396	CbGpPWpGaD
Pomalidomide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	3.82e-05	0.000393	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—MAPK8—rheumatoid arthritis	3.79e-05	0.00039	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—ADIPOQ—rheumatoid arthritis	3.78e-05	0.00039	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL1B—rheumatoid arthritis	3.77e-05	0.000388	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—rheumatoid arthritis	3.77e-05	0.000388	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	3.7e-05	0.000381	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—IL1B—rheumatoid arthritis	3.68e-05	0.00038	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—TGFB1—rheumatoid arthritis	3.66e-05	0.000377	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—IL1B—rheumatoid arthritis	3.55e-05	0.000366	CbGpPWpGaD
Pomalidomide—CYP1A2—Arachidonic acid metabolism—PTGS2—rheumatoid arthritis	3.52e-05	0.000363	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—NFKB1—rheumatoid arthritis	3.52e-05	0.000362	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—rheumatoid arthritis	3.51e-05	0.000362	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—rheumatoid arthritis	3.5e-05	0.000361	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—rheumatoid arthritis	3.5e-05	0.00036	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—rheumatoid arthritis	3.49e-05	0.00036	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—IL6—rheumatoid arthritis	3.49e-05	0.000359	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—MAPK8—rheumatoid arthritis	3.47e-05	0.000358	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—rheumatoid arthritis	3.44e-05	0.000355	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—PRKCQ—rheumatoid arthritis	3.44e-05	0.000354	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—NFKB1—rheumatoid arthritis	3.44e-05	0.000354	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—FADS2—rheumatoid arthritis	3.43e-05	0.000353	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—TGFB1—rheumatoid arthritis	3.39e-05	0.000349	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—rheumatoid arthritis	3.39e-05	0.000349	CbGpPWpGaD
Pomalidomide—TNF—TNF alpha Signaling Pathway—IL6—rheumatoid arthritis	3.37e-05	0.000347	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—NFKB1—rheumatoid arthritis	3.31e-05	0.000341	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—rheumatoid arthritis	3.27e-05	0.000337	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IFNG—rheumatoid arthritis	3.27e-05	0.000337	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—MAPK8—rheumatoid arthritis	3.26e-05	0.000335	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IFNG—rheumatoid arthritis	3.19e-05	0.000329	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—VEGFA—rheumatoid arthritis	3.19e-05	0.000329	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—STAT1—rheumatoid arthritis	3.17e-05	0.000326	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—IL6—rheumatoid arthritis	3.1e-05	0.000319	CbGpPWpGaD
Pomalidomide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	3.09e-05	0.000319	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	3.06e-05	0.000315	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—CXCL8—rheumatoid arthritis	3.04e-05	0.000313	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—TP53—rheumatoid arthritis	3.01e-05	0.00031	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	2.99e-05	0.000308	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—CXCL8—rheumatoid arthritis	2.97e-05	0.000306	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—rheumatoid arthritis	2.97e-05	0.000306	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SYVN1—rheumatoid arthritis	2.96e-05	0.000305	CbGpPWpGaD
Pomalidomide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	2.95e-05	0.000303	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	2.94e-05	0.000303	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—PTK2—rheumatoid arthritis	2.93e-05	0.000301	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL1B—rheumatoid arthritis	2.91e-05	0.0003	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	2.91e-05	0.000299	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL2—rheumatoid arthritis	2.9e-05	0.000299	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	2.85e-05	0.000293	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL1B—rheumatoid arthritis	2.85e-05	0.000293	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL2—rheumatoid arthritis	2.84e-05	0.000292	CbGpPWpGaD
Pomalidomide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—rheumatoid arthritis	2.78e-05	0.000287	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—TGFB1—rheumatoid arthritis	2.76e-05	0.000284	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—IL6—rheumatoid arthritis	2.76e-05	0.000284	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—MMP9—rheumatoid arthritis	2.75e-05	0.000283	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—rheumatoid arthritis	2.72e-05	0.00028	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	2.71e-05	0.00028	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—TNF—rheumatoid arthritis	2.67e-05	0.000275	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ACAN—rheumatoid arthritis	2.64e-05	0.000272	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	2.57e-05	0.000264	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	2.57e-05	0.000264	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—IL6—rheumatoid arthritis	2.55e-05	0.000263	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—rheumatoid arthritis	2.54e-05	0.000262	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—rheumatoid arthritis	2.54e-05	0.000262	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	2.49e-05	0.000257	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	2.49e-05	0.000257	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—rheumatoid arthritis	2.49e-05	0.000257	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SLC25A12—rheumatoid arthritis	2.48e-05	0.000255	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—FADS2—rheumatoid arthritis	2.43e-05	0.00025	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—TP53—rheumatoid arthritis	2.42e-05	0.00025	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL6—rheumatoid arthritis	2.42e-05	0.000249	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—VEGFA—rheumatoid arthritis	2.41e-05	0.000248	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—rheumatoid arthritis	2.4e-05	0.000247	CbGpPWpGaD
Pomalidomide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	2.39e-05	0.000246	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	2.39e-05	0.000246	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—LEP—rheumatoid arthritis	2.35e-05	0.000242	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PLD4—rheumatoid arthritis	2.29e-05	0.000236	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—TP53—rheumatoid arthritis	2.27e-05	0.000234	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TGFB1—rheumatoid arthritis	2.26e-05	0.000233	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PLB1—rheumatoid arthritis	2.24e-05	0.000231	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—TGFB1—rheumatoid arthritis	2.21e-05	0.000228	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ACAN—rheumatoid arthritis	2.21e-05	0.000227	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—IL6ST—rheumatoid arthritis	2.21e-05	0.000227	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL6—rheumatoid arthritis	2.21e-05	0.000227	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—IL6—rheumatoid arthritis	2.16e-05	0.000222	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TNF—rheumatoid arthritis	2.11e-05	0.000218	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	2.09e-05	0.000216	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SLC25A12—rheumatoid arthritis	2.08e-05	0.000214	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—RBPJ—rheumatoid arthritis	2.07e-05	0.000213	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—TNF—rheumatoid arthritis	2.07e-05	0.000213	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	2.05e-05	0.000211	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GC—rheumatoid arthritis	2.02e-05	0.000208	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PTGES—rheumatoid arthritis	2.02e-05	0.000208	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—IL6R—rheumatoid arthritis	1.97e-05	0.000203	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—FADS2—rheumatoid arthritis	1.94e-05	0.0002	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	1.9e-05	0.000196	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—MMP2—rheumatoid arthritis	1.88e-05	0.000194	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PLB1—rheumatoid arthritis	1.88e-05	0.000193	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TP53—rheumatoid arthritis	1.86e-05	0.000192	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	1.85e-05	0.00019	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—B3GNT2—rheumatoid arthritis	1.83e-05	0.000188	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ACP5—rheumatoid arthritis	1.83e-05	0.000188	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	1.82e-05	0.000187	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—TYK2—rheumatoid arthritis	1.79e-05	0.000185	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL6—rheumatoid arthritis	1.71e-05	0.000176	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	1.68e-05	0.000173	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MED1—rheumatoid arthritis	1.65e-05	0.00017	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—BGN—rheumatoid arthritis	1.65e-05	0.00017	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TLE3—rheumatoid arthritis	1.65e-05	0.00017	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—POMC—rheumatoid arthritis	1.64e-05	0.000169	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PLD4—rheumatoid arthritis	1.62e-05	0.000167	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	1.61e-05	0.000166	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ACAN—rheumatoid arthritis	1.57e-05	0.000161	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	1.54e-05	0.000159	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—B3GNT2—rheumatoid arthritis	1.53e-05	0.000158	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ACP5—rheumatoid arthritis	1.53e-05	0.000158	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—rheumatoid arthritis	1.51e-05	0.000156	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SLC11A1—rheumatoid arthritis	1.5e-05	0.000155	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—FADS2—rheumatoid arthritis	1.5e-05	0.000154	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NFATC1—rheumatoid arthritis	1.49e-05	0.000153	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SLC25A12—rheumatoid arthritis	1.47e-05	0.000152	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	1.44e-05	0.000148	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GC—rheumatoid arthritis	1.43e-05	0.000147	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTGES—rheumatoid arthritis	1.43e-05	0.000147	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—MMP9—rheumatoid arthritis	1.41e-05	0.000146	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—NFKB1—rheumatoid arthritis	1.4e-05	0.000144	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NCF2—rheumatoid arthritis	1.39e-05	0.000143	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—BGN—rheumatoid arthritis	1.38e-05	0.000142	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PLB1—rheumatoid arthritis	1.33e-05	0.000137	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	1.31e-05	0.000135	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PLD4—rheumatoid arthritis	1.29e-05	0.000133	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	1.29e-05	0.000133	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SAA1—rheumatoid arthritis	1.27e-05	0.000131	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—VEGFA—rheumatoid arthritis	1.27e-05	0.000131	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—POMC—rheumatoid arthritis	1.27e-05	0.000131	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ALOX5—rheumatoid arthritis	1.27e-05	0.000131	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	1.27e-05	0.000131	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ACAN—rheumatoid arthritis	1.25e-05	0.000129	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NCF1—rheumatoid arthritis	1.25e-05	0.000128	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ENO1—rheumatoid arthritis	1.23e-05	0.000127	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CD28—rheumatoid arthritis	1.2e-05	0.000124	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	1.19e-05	0.000123	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLC25A12—rheumatoid arthritis	1.17e-05	0.000121	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MED1—rheumatoid arthritis	1.17e-05	0.00012	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—TGFB1—rheumatoid arthritis	1.16e-05	0.00012	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GC—rheumatoid arthritis	1.14e-05	0.000118	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTGES—rheumatoid arthritis	1.14e-05	0.000118	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—UBE2D1—rheumatoid arthritis	1.13e-05	0.000116	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	1.12e-05	0.000115	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ADRBK1—rheumatoid arthritis	1.09e-05	0.000113	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	1.09e-05	0.000112	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—B3GNT2—rheumatoid arthritis	1.08e-05	0.000112	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ACP5—rheumatoid arthritis	1.08e-05	0.000112	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PLB1—rheumatoid arthritis	1.06e-05	0.000109	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ENO1—rheumatoid arthritis	1.03e-05	0.000107	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	1.02e-05	0.000105	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.02e-05	0.000105	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PRKCQ—rheumatoid arthritis	1.01e-05	0.000104	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	9.99e-06	0.000103	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—STAT1—rheumatoid arthritis	9.93e-06	0.000102	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—BGN—rheumatoid arthritis	9.77e-06	0.000101	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	9.64e-06	9.94e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MED1—rheumatoid arthritis	9.32e-06	9.6e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	9.07e-06	9.34e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALOX5—rheumatoid arthritis	8.99e-06	9.26e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	8.99e-06	9.26e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GC—rheumatoid arthritis	8.82e-06	9.09e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	8.82e-06	9.09e-05	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—IL6—rheumatoid arthritis	8.77e-06	9.04e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ACP5—rheumatoid arthritis	8.66e-06	8.92e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—B3GNT2—rheumatoid arthritis	8.66e-06	8.92e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	8.2e-06	8.45e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—BGN—rheumatoid arthritis	7.8e-06	8.03e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CCR5—rheumatoid arthritis	7.59e-06	7.82e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CAT—rheumatoid arthritis	7.44e-06	7.67e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MTHFR—rheumatoid arthritis	7.42e-06	7.64e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HLA-A—rheumatoid arthritis	7.4e-06	7.62e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ENO1—rheumatoid arthritis	7.33e-06	7.55e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MED1—rheumatoid arthritis	7.19e-06	7.41e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALOX5—rheumatoid arthritis	7.18e-06	7.39e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	6.85e-06	7.06e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	6.68e-06	6.89e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	6.68e-06	6.89e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IL6ST—rheumatoid arthritis	6.48e-06	6.68e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS2—rheumatoid arthritis	6.43e-06	6.63e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	6.31e-06	6.5e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CD80—rheumatoid arthritis	6.24e-06	6.43e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MTHFR—rheumatoid arthritis	6.21e-06	6.4e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—BGN—rheumatoid arthritis	6.02e-06	6.2e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ENO1—rheumatoid arthritis	5.85e-06	6.03e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IL6R—rheumatoid arthritis	5.79e-06	5.96e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	5.75e-06	5.93e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	5.54e-06	5.71e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CAT—rheumatoid arthritis	5.28e-06	5.43e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TYK2—rheumatoid arthritis	5.27e-06	5.43e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS3—rheumatoid arthritis	5.17e-06	5.33e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	5.03e-06	5.19e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—POMC—rheumatoid arthritis	4.97e-06	5.12e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CD4—rheumatoid arthritis	4.77e-06	4.91e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ALB—rheumatoid arthritis	4.53e-06	4.67e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	4.52e-06	4.65e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	4.4e-06	4.54e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NOS3—rheumatoid arthritis	4.33e-06	4.46e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CAT—rheumatoid arthritis	4.21e-06	4.34e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—POMC—rheumatoid arthritis	3.52e-06	3.63e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	3.51e-06	3.62e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TGFB1—rheumatoid arthritis	3.42e-06	3.52e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CAT—rheumatoid arthritis	3.25e-06	3.35e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALB—rheumatoid arthritis	3.21e-06	3.31e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NOS3—rheumatoid arthritis	3.07e-06	3.16e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—POMC—rheumatoid arthritis	2.81e-06	2.9e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	2.81e-06	2.89e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	2.71e-06	2.79e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IL6—rheumatoid arthritis	2.58e-06	2.66e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALB—rheumatoid arthritis	2.56e-06	2.64e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	2.45e-06	2.53e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	2.24e-06	2.31e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—POMC—rheumatoid arthritis	2.17e-06	2.23e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALB—rheumatoid arthritis	1.98e-06	2.04e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	1.89e-06	1.95e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	1.73e-06	1.78e-05	CbGpPWpGaD
